110 related articles for article (PubMed ID: 1675276)
1. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the rat during chronic dapsone administration.
Coleman MD; Tingle MD; Park BK
J Pharm Pharmacol; 1991 Mar; 43(3):186-90. PubMed ID: 1675276
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat.
Coleman MD; Russell RM; Tingle MD; Park BK
J Pharm Pharmacol; 1992 Feb; 44(2):114-8. PubMed ID: 1352810
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of dapsone-induced methaemoglobinaemia in the rat isolated perfused liver.
Coleman MD; Hoaksey PE; Breckenridge AM; Park BK
J Pharm Pharmacol; 1990 May; 42(5):302-7. PubMed ID: 1976775
[TBL] [Abstract][Full Text] [Related]
4. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
Coleman MD; Scott AK; Breckenridge AM; Park BK
Br J Clin Pharmacol; 1990 Nov; 30(5):761-7. PubMed ID: 2271376
[TBL] [Abstract][Full Text] [Related]
5. Effects of H(2)-receptor antagonists on dapsone-induced methaemoglobinaemia in rats.
Malfará WR; Pereira CP; Santos AC; Queiroz RH
Pharmacol Res; 2002 Apr; 45(4):269-73. PubMed ID: 12030789
[TBL] [Abstract][Full Text] [Related]
6. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
Coleman MD; Rhodes LE; Scott AK; Verbov JL; Friedmann PS; Breckenridge AM; Park BK
Br J Clin Pharmacol; 1992 Sep; 34(3):244-9. PubMed ID: 1389948
[TBL] [Abstract][Full Text] [Related]
7. Gonadal influence on the metabolism and haematological toxicity of dapsone in the rat.
Coleman MD; Tingle MD; Winn MJ; Park BK
J Pharm Pharmacol; 1990 Oct; 42(10):698-703. PubMed ID: 1982141
[TBL] [Abstract][Full Text] [Related]
8. A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite.
Ahmadi M; Khalaf LF; Smith HJ; Nicholls PJ
J Pharm Pharmacol; 1996 Feb; 48(2):228-32. PubMed ID: 8935178
[TBL] [Abstract][Full Text] [Related]
9. The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.
Tingle MD; Coleman MD; Park BK
Br J Clin Pharmacol; 1991 Jul; 32(1):120-3. PubMed ID: 1888631
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of dapsone-induced methaemoglobinaemia in the rat.
Coleman MD; Winn MJ; Breckenridge AM; Park BK
Biochem Pharmacol; 1990 Feb; 39(4):802-5. PubMed ID: 2306285
[No Abstract] [Full Text] [Related]
11. Sex-dependent sensitivity to dapsone-induced methaemoglobinaemia in the rat.
Coleman MD; Winn MJ; Breckenridge AM; Park BK
Biochem Pharmacol; 1990 Feb; 39(4):805-9. PubMed ID: 2306286
[No Abstract] [Full Text] [Related]
12. An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.
Tingle MD; Coleman MD; Park BK
Br J Clin Pharmacol; 1990 Dec; 30(6):829-38. PubMed ID: 2288829
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the metabolism and toxicity of dapsone in rat, mouse and man.
Tingle MD; Mahmud R; Maggs JL; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 1997 Nov; 283(2):817-23. PubMed ID: 9353403
[TBL] [Abstract][Full Text] [Related]
14. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy.
Rhodes LE; Tingle MD; Park BK; Chu P; Verbov JL; Friedmann PS
Br J Dermatol; 1995 Feb; 132(2):257-62. PubMed ID: 7888363
[TBL] [Abstract][Full Text] [Related]
15. An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro.
Coleman MD; Tingle MD; Hussain F; Storr RC; Park BK
J Pharm Pharmacol; 1991 Nov; 43(11):779-84. PubMed ID: 1686906
[TBL] [Abstract][Full Text] [Related]
16. N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity.
Gill HJ; Tingle MD; Park BK
Br J Clin Pharmacol; 1995 Dec; 40(6):531-8. PubMed ID: 8703658
[TBL] [Abstract][Full Text] [Related]
17. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
Irshaid Y; Adedoyin A; Lotze M; Branch RA
Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
[TBL] [Abstract][Full Text] [Related]
18. Dapsone toxicity: some current perspectives.
Coleman MD
Gen Pharmacol; 1995 Nov; 26(7):1461-7. PubMed ID: 8690232
[TBL] [Abstract][Full Text] [Related]
19. The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
Winter HR; Trapnell CB; Slattery JT; Jacobson M; Greenspan DL; Hooton TM; Unadkat JD
Clin Pharmacol Ther; 2004 Dec; 76(6):579-87. PubMed ID: 15592329
[TBL] [Abstract][Full Text] [Related]
20. Combined dapsone and clofazimine intoxication.
Hoetelmans RM; Otten JM; Koks CH; Soesan M; Beijnen JH
Hum Exp Toxicol; 1996 Aug; 15(8):625-8. PubMed ID: 8863056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
